Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Salicylic acid
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Salicylic acid 16.7% / Lactic acid 16.7% paint
1307000M0AAAWAW
|
Salicylic acid (Warts/Calluses) | Salicylic acid | Skin | 8,371 |
|
Salicylic acid 12% / Lactic acid 4% gel
1307000M0AAAVAV
|
Salicylic acid (Warts/Calluses) | Salicylic acid | Skin | 3,869 |
|
Salactol paint
1307000M0BPAAAW
|
Salactol | Salicylic acid | Skin | 3,473 |
|
Salicylic acid 26% gel
1307000M0AABMBM
|
Salicylic acid (Warts/Calluses) | Salicylic acid | Skin | 2,823 |
|
Salatac gel
1307000M0BJAAAV
|
Salatac | Salicylic acid | Skin | 2,553 |
|
Bazuka Extra Strength 26% gel
1307000M0BXABBM
|
Bazuka | Salicylic acid | Skin | 1,199 |
|
Salicylic acid 26% solution
1307000M0AABABA
|
Salicylic acid (Warts/Calluses) | Salicylic acid | Skin | 935 |
|
Salicylic acid 16.7% / Lactic acid 15% paint
1307000M0AABYBY
|
Salicylic acid (Warts/Calluses) | Salicylic acid | Skin | 930 |
|
Bazuka gel
1307000M0BXAAAV
|
Bazuka | Salicylic acid | Skin | 883 |
|
Salicylic acid 50% ointment
1307000M0AAAEAE
|
Salicylic acid (Warts/Calluses) | Salicylic acid | Skin | 549 |
|
Salicylic acid 2% ointment
1305020S0AAABAB
|
Salicylic acid (Psoriasis) | Salicylic acid | Skin | 457 |
|
Salicylic acid 40% medicated plasters
1307000M0AABSBS
|
Salicylic acid (Warts/Calluses) | Salicylic acid | Skin | 423 |
|
Duofilm paint
1307000M0BKABBY
|
Duofilm | Salicylic acid | Skin | 372 |
|
Verrugon complete 50% ointment
1307000M0BFAAAE
|
Verrugon | Salicylic acid | Skin | 316 |
|
Scholl Corn Removal 40% plasters washproof
1307000M0BQAFBS
|
Scholl (Corn & Verruca) | Salicylic acid | Skin | 206 |
|
Salicylic acid 10% ointment in a base
1307000M0AABVBV
|
Salicylic acid (Warts/Calluses) | Salicylic acid | Skin | 159 |
|
Bazuka Extra Strength Treatment 26% gel
1307000M0BXADBM
|
Bazuka | Salicylic acid | Skin | 113 |
|
Occlusal 26% solution
1307000M0BTAABA
|
Occlusal | Salicylic acid | Skin | 108 |
|
Salicylic acid 5% ointment in a base
1305020S0AACZCZ
|
Salicylic acid (Psoriasis) | Salicylic acid | Skin | 86 |
|
Salicylic acid 20% ointment in a base
1307000M0AABZBZ
|
Salicylic acid (Warts/Calluses) | Salicylic acid | Skin | 76 |
|
Bazuka Treatment gel
1307000M0BXACAV
|
Bazuka | Salicylic acid | Skin | 40 |
|
Salicylic acid 2% in Aqueous cream
1305020S0AACSCS
|
Salicylic acid (Psoriasis) | Salicylic acid | Skin | 40 |
|
Zinc and Salicylic acid paste
1305020S0AACUCU
|
Salicylic acid (Psoriasis) | Salicylic acid | Skin | 34 |
|
Salicylic acid 10% in Aqueous cream
1305020S0AACRCR
|
Salicylic acid (Psoriasis) | Salicylic acid | Skin | 31 |
|
Salicylic acid 5% cream
1305020S0AAA4A4
|
Salicylic acid (Psoriasis) | Salicylic acid | Skin | 24 |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.